It is Not Age That Lowers NAD - It is This! | Dr Charles Brenner

Transcript

and the McDermott group at Northwestern University, which is the top clinical triing group for peripheral artery disease maybe anywhere, did a trial of nicotenomide ribocide versus placebo versus NR plus resveratrol, by the way, as a third arm. And um they found that nicotenomide ribocide met their primary endpoint. So it improved walking speed for... Read More